Carcinoma of the ovary.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Epidemiology and Biostatistics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11385772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Benefits of laparoscopic approach in early-stage ovarian cancer and ovarian masses.

  2025cites this paper
• KCMF1 regulates HRI ubiquitination to inhibit the integrated stress response in ovarian cancer.

  2025cites this paper
• Clinical Investigation into Survival Outcomes Among Stage IV Epithelial Ovarian Cancer Patients Receiving Curative Treatment: Indian Setting

  2024cites this paper
• Leveraging mid-infrared spectroscopic imaging and deep learning for tissue subtype classification in ovarian cancer.

  2022cites this paper
• Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer

  2021cites this paper
• The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling

  2021cites this paper
• Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report

  2020cites this paper
• Clinical presentation, diagnosis and management of therapy‐related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly‐ADP‐ribose polymerase inhibitors: A single‐center experience

  2020cites this paper
• First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research

  2020cites this paper
• Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature

  2019cites this paper
• Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases

  2019cites this paper
• The Pathology of Pelvic-Ovarian Epithelial (Epithelial-Stromal) Tumors

  2018cites this paper
• Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.

  2018cites this paper
• Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells

  2018cites this paper
• Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

  2018cites this paper
• An Evaluation of Frozen Section and Lymph Node Dissection Results for Mucinous Ovarian Tumors

  2017cites this paper
• 1st Evidence-based Italian Consensus Conference on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Ovarian Cancer

  2017cites this paper
• Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma

  2017cites this paper
• Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.

  2016cites this paper
• Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial.

  2016cites this paper
• Diagnostic Accuracy of Serum Kallikrein-Related Peptidases for Ovarian Cancer: A Systematic Review and Meta-Analysis

  2016cites this paper
• FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.

  2016cites this paper
• MUC16/CA125:: A Candidate Tumor Marker for Diagnosis and Therapy in Ovarian Cancer

  2015cites this paper
• Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance

  2015cites this paper
• Positive Intraoperative Peritoneal Lavage Cytology is a Negative Prognostic Factor in Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Study

  2015cites this paper
• The value of peritoneal washing cytology during intra-abdominal surgery for female genital tract neoplasms.

  2014cites this paper
• Retrospective analysis of outcomes of secondary debulking surgery for recurrent epithelial ovarian cancer with favorable prognostic factors

  2014cites this paper
• Epigenetic quantification of tumor-infiltrating T-lymphocytes in epithelial ovarian tumors

  2014cites this paper
• Screening Postmenopausal Women for Ovarian Cancer

  2014cites this paper
• Oxidative stress in breast and gynaecological carcinogenesis

  2014cites this paper
• Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.

  2014cites this paper
• Profil des cancers gynécologiques et mammaires à Yaoundé - Cameroun

  2014cites this paper
• Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.

  2014cites this paper
• Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

  2013cites this paper
• Inherited breast and ovarian cancer: a review of the available genetic counselling and testing services in Johannesburg

  2013cites this paper
• New Hypothesis on Pathogenesis of Ovarian Cancer Lead to Future Tailored Approaches

  2013cites this paper
• Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management

  2013cites this paper
• Outcomes of fertility‐sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer

  2013cites this paper
• Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study

  2012cites this paper
• High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

  2012cites this paper
• Kapitel 19 – Mammakarzinom und gynäkologische Malignome

  2012cites this paper
• Immunohistochemical Localization of HE4 in Benign, Borderline, and Malignant Lesions of the Ovary

  2012cites this paper
• Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.

  2012cites this paper
• Contrast Imaging Ultrasound Detects Abnormalities in the Marmoset Ovary

  2012cites this paper
• Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer

  2012cites this paper
• Vaccine-based clinical trials in ovarian cancer

  2011cites this paper
• Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review

  2011cites this paper
• Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment

  2011cites this paper
• Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.

  2011cites this paper
• Utility of peritoneal lavage cytology during laparoscopic salpingo‐oophorectomy: a retrospective analysis

  2011cites this paper
• Die Heterogenität des Ovarialkarzinoms

  2011cites this paper
• A call for prospective studies in early‐stage ovarian cancer

  2010cites this paper
• Les curages lymphatiques dans les cancers de l'ovaire.Commentaire

  2010cites this paper
• Prevalence of cysts in epithelial ovarian cancer.

  2010cites this paper
• CONTROLLING TRANSDUCTION AND REPLICATION OF ONCOLYTIC ADENOVIRUSES

  2010cites this paper
• First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directions

  2010cites this paper
• Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute

  2010cites this paper
• Platinum‐based adjuvant chemotherapy for early‐stage epithelial ovarian cancer: single or combination chemotherapy?

  2010cites this paper
• Ovarian Pathology in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations, Emphasizing the Differential Diagnosis of Occult Primary and Metastatic Carcinoma

  2009cites this paper
• Intra‐abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer

  2009cites this paper
• Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

  2009cites this paper
• Fluorescence diagnosis and photodynamic therapy in intra-abdominal gynecologic diseases and breast cancer – A review

  2009cites this paper
• Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

  2009cites this paper
• Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review.

  2009cites this paper
• Chapter 11 – Surface Epithelial Stromal Tumors of the Ovary

  2009cites this paper
• A Comparative Analysis of Lymphatic Vessel Density in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) With and Without Lymph Node Involvement

  2008cites this paper
• Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.

  2008cites this paper
• A third evaluation of tertiary cytoreduction

  2008cites this paper
• Fertility after the treatment of gynecologic tumors.

  2008cites this paper
• Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer

  2008cites this paper
• Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2

  2008cites this paper
• Molecular mechanisms for individualized cancer care.

  2008cites this paper
• Place du curage lombo-aortique et pelvien dans les cancers épithéliaux de l’ovaire

  2008cites this paper
• Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.

  2007cites this paper
• LINE- 1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer

  2007cites this paper
• Gonadotropins and ovarian cancer.

  2007cites this paper
• Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion

  2007cites this paper
• Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up.

  2007cites this paper
• Ovarian cancer: an overview of treatment options.

  2007cites this paper
• Epithelial ovarian cancer : A clinical epidemiological approach on diagnosis and treatment

  2007cites this paper
• Operative management of primary epithelial ovarian cancer

  2007cites this paper
• Hormones and genetics caught in the crossfire of preventive medicine.

  2007cites this paper
• 17 – Use of Microarray in Immunohistochemical Localization of SMAD in Ovarian Carcinoma

  2006cites this paper
• Evolving Role of Serum Biomarkers in the Management of Ovarian Cancer

  2006cites this paper
• Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer.

  2006cites this paper
• Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

  2006cites this paper
• Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.

  2006cites this paper
• Ovarian cancer death reduction for women at high risk: Workload implications for gynaecology services

  2006cites this paper
• B7-H4 overexpression in ovarian tumors.

  2006cites this paper
• 5 – Role of BRCA1/BRCA2 in Ovarian, Fallopian Tube, and Peritoneal Papillary Serous Carcinoma

  2006cites this paper
• Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

  2006cites this paper
• Fluorescence staining of human ovarian cancer tissue following application of 5‐aminolevulinic acid: Fluorescence microscopy studies

  2006cites this paper
• Histologic types of epithelial ovarian cancer: have they different risk factors?

  2005cites this paper
• Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

  2005cites this paper
• Presenting symptoms of epithelial ovarian cancer

  2005cites this paper
• The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma

  2005cites this paper
• Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.

  2005cites this paper
• Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis.

  2005cites this paper
• Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

  2004cites this paper
• Screening postmenopausal women for ovarian cancer: a systematic review.

  2004cites this paper